INSMED INC
Biopharmaceutical therapeutics for serious diseases including orphan lung infections and bronchiectasis
- Sector
- Biotech
- Headquarters
- RICHMOND, VA
- Latest Form D
- $83.7M, Dec 2010
- Total capital
- $83.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $83.7M
- 1 Form D · last Dec 2010
- 190 months since last filing
- Federal contracts
- $139K
- 9 awards · Veterans Affairs
- Rank in Biotech#314 of 4373
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Federal contractVeterans Affairs · Rezdiffra 80 Mg$31K
- Federal contractVeterans Affairs · Arikayce (amikacin) 590MG/8.4ML$10K
- Federal contractVeterans Affairs · Arikayce (amikacin) 590MG/8.4ML$10K
- Federal contractVeterans Affairs · Arikayce (amikacin) 590MG/8.4ML$10K
- Federal contractVeterans Affairs · Emergency Pharmacy Order.$10K
- Federal contractVeterans Affairs · Belzutifan (welireg) 40 Mg$10K
- Federal contractVeterans Affairs · Emergency Amikacin$27K
- Private capital raisedForm D · SEC · 1st filing$83.7M
Show 2 earlier federal awards
- Federal contractVeterans Affairs · *emergency* Arikayce (amikacin Liposome) Inhalation Suspension 28 Day Pack$15K
- Federal contractVeterans Affairs · Arikayce$15K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Donald Hayden, Jr.DirectorNamed in SEC Form D filings
- Kevin P TullyExecutive OfficerNamed in SEC Form D filings
- Melvin SharokyDirectorNamed in SEC Form D filings
- Nicholas P LaBellaExecutive OfficerNamed in SEC Form D filings
- Randall WhitcombDirectorNamed in SEC Form D filings
- Renu P GuptaExecutive OfficerNamed in SEC Form D filings
Show all 8 people
- Steinar EngelsenDirectorNamed in SEC Form D filings
- Timothy P WhittenExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingMethods For Extracting Neutrophil Serine Proteases And Treating Dipeptidyl Peptidase 1-MEDIATED ConditionsUSPTOApplication 18017261
- PendingSystems For Treating Pulmonary InfectionsUSPTOApplication 15379804
- PendingCompositions And Methods For Treating Bacterial InfectionsUSPTOApplication 15356224
Show all 8 patent records
- Methods For Extracting Neutrophil Serine Proteases And Treating Dipeptidyl Peptidase 1-MEDIATED ConditionsOct 5, 2023 · Application 18017261Pending
- Systems For Treating Pulmonary InfectionsJul 13, 2017 · Application 15379804Pending
- Compositions And Methods For Treating Bacterial InfectionsJun 15, 2017 · Application 15356224Pending
- High Delivery Rates For Lipid Based Drug Formulations, And Methods Of Treatment ThereofJan 19, 2017 · Application 15277667Pending
- Methods For Extracting Neutrophil Serine Proteases And Treating Dipeptidyl Peptidase 1-MEDIATED ConditionsApplication PCTUS2021042199Pending
- Purified RHIGF-I/RHIGFBP-3 Complexes And Their Method Of ManufactureApplication PCTUS2005046040Pending
- Recombinant Igf Expression SystemsApplication PCTUS2004019070Pending
- Methods For Treating Lung Cancer Using Insulin-like Growth Factor Binding PROTEIN-3Application PCTUS2003028354Pending
Related companies, and why
- DRVISION TECHNOLOGIES LLCSimilar federal contract value in Biotech · $144K in contracts
- 28bio, Inc.Similar federal contract value in Biotech · $143K in contracts
- HAGER BIOSCIENCES, LLCSimilar federal contract value in Biotech · $142K in contracts
- ATLASXOMICS INCSimilar federal contract value in Biotech · $137K in contracts
- SIMULATIONS PLUS, INC.Similar federal contract value in Biotech · $136K in contracts
- NEUROSETTA LLCSimilar federal contract value in Biotech · $135K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .